Literature DB >> 15557454

Microarray analysis of the failure of filtering blebs in a rat model of glaucoma filtering surgery.

Douglas W Esson1, Michael P Popp, Li Liu, Gregory S Schultz, Mark B Sherwood.   

Abstract

PURPOSE: To generate data concerning changes in levels of protein expression associated with wound healing and bleb failure in a rat model of glaucoma filtration surgery (GFS), and to identify factors that may play a role in this process.
METHODS: Of 36 Sprague-Dawley rats, GFS was performed on 27 by introducing a silicone cannula through a scleral tunnel under a conjunctival flap, resulting in aqueous-filtering blebs that failed over 8 to 13 days. The additional nine rats were used as the nonsurgical control. Nine blebs were harvested at each of days 0, 2, 5, and 12 and pooled, yielding three replicates of three blebs per time point. RNA was extracted, labeled, and hybridized to 230A rat GeneChip arrays (Affymetrix, Santa Clara, CA).
RESULTS: Of the 15,924 probe sets/genes present on the array, 923 genes were indicated to have a significant treatment effect at P < 0.005. Eight gene expression clusters were identified that could be broadly classified into three basic patterns. These were an increase on day 2, a decrease on day 2, or an increase on either day 5 or 12. The greatest change occurred between days 0 and 2. The most heavily populated functional categories included growth factors, structural proteins, and matrix metalloproteinases.
CONCLUSIONS: This study represents the first large-scale gene expression analysis after GFS. Expression patterns for known mediators of the bleb scarring process, including transforming growth factor-beta, connective tissue growth factor, and matrix metalloproteinases, were confirmed, and a number of mediators not previously associated with this process were identified.

Entities:  

Mesh:

Year:  2004        PMID: 15557454     DOI: 10.1167/iovs.04-0375

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

Review 1.  Focus on molecular events in the anterior chamber leading to glaucoma.

Authors:  Sergio Claudio Saccà; Alberto Izzotti
Journal:  Cell Mol Life Sci       Date:  2013-10-19       Impact factor: 9.261

2.  Post-trabeculectomy topical bevacizumab preventing bleb failure: a preliminary study.

Authors:  Shashi Kumar Bhasker; Sandeep Saxena; Kamlesh Singh
Journal:  J Ocul Biol Dis Infor       Date:  2013-06-27

3.  TGF-β1 Induces Interlukin-11 Expression and Pro-Fibrotic Effect by DNA Demethylation in Subconjunctival Fibroblasts.

Authors:  Shuhao Fu; Zhaozeng Lu; Wen Ye
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-12       Impact factor: 2.650

4.  A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).

Authors:  Mark Brian Sherwood
Journal:  Trans Am Ophthalmol Soc       Date:  2006

5.  Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma.

Authors:  ZhiHua Shi; Marcelo Rudzinski; Karen Meerovitch; Frédéric Lebrun-Julien; Elena Birman; Adriana Di Polo; H Uri Saragovi
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

Review 6.  Looking into the future: Gene and cell therapies for glaucoma.

Authors:  András M Komáromy; Kristin L Koehl; Shin Ae Park
Journal:  Vet Ophthalmol       Date:  2021-01-07       Impact factor: 1.644

7.  Development of a microarray chip for gene expression in rabbit ocular research.

Authors:  Michael P Popp; Li Liu; Adrian Timmers; Douglas W Esson; Lineu Shiroma; Craig Meyers; Scott Berceli; Ming Tao; Graeme Wistow; Gregory S Schultz; Mark B Sherwood
Journal:  Mol Vis       Date:  2007-02-02       Impact factor: 2.367

8.  Withaferin A effectively targets soluble vimentin in the glaucoma filtration surgical model of fibrosis.

Authors:  Paola Bargagna-Mohan; Sunil P Deokule; Kyle Thompson; John Wizeman; Cidambi Srinivasan; Sunil Vooturi; Uday B Kompella; Royce Mohan
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

9.  Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy.

Authors:  Florentina Joyce Freiberg; Juliane Matlach; Franz Grehn; Sabine Karl; Thomas Klink
Journal:  Clin Ophthalmol       Date:  2013-06-20

10.  Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs.

Authors:  Tobias Meyer-Ter-Vehn; Franz Grehn; Günther Schlunck
Journal:  Mol Vis       Date:  2008-01-25       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.